Dicot AB
Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It develops LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden.
Dicot AB (DICOT) - Total Assets
Latest total assets as of December 2025: Skr85.50 Million SEK
Based on the latest financial reports, Dicot AB (DICOT) holds total assets worth Skr85.50 Million SEK as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Dicot AB - Total Assets Trend (2021–2025)
This chart illustrates how Dicot AB’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Dicot AB - Asset Composition Analysis
Current Asset Composition (December 2025)
Dicot AB's total assets of Skr85.50 Million consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 80.9% |
| Accounts Receivable | Skr8.30 Million | 9.7% |
| Inventory | Skr8.00 Million | 9.4% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr0.00 | 0.0% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how Dicot AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dicot AB's current assets represent 100.0% of total assets in 2025, an increase from 99.9% in 2021.
- Cash Position: Cash and equivalents constituted 80.9% of total assets in 2025, down from 95.5% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 9.7% of total assets.
Dicot AB Competitors by Total Assets
Key competitors of Dicot AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Dicot AB - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Dicot AB generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Dicot AB is currently not profitable relative to its asset base.
Dicot AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.07 | 10.34 | 2.67 |
| Quick Ratio | 6.40 | 9.89 | 1.98 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr73.40 Million | Skr 111.67 Million | Skr 17.45 Million |
Dicot AB - Advanced Valuation Insights
This section examines the relationship between Dicot AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.06 |
| Latest Market Cap to Assets Ratio | 0.65 |
| Asset Growth Rate (YoY) | -30.8% |
| Total Assets | Skr85.50 Million |
| Market Capitalization | $55.17 Million USD |
Valuation Analysis
Below Book Valuation: The market values Dicot AB's assets below their book value (0.65 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Dicot AB's assets decreased by 30.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Dicot AB (2021–2025)
The table below shows the annual total assets of Dicot AB from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr85.50 Million | -30.84% |
| 2024-12-31 | Skr123.62 Million | +130.83% |
| 2023-12-31 | Skr53.55 Million | +332.90% |
| 2022-12-31 | Skr12.37 Million | -61.06% |
| 2021-12-31 | Skr31.77 Million | -- |